155 related articles for article (PubMed ID: 15600263)
1. Intravenous treatment of hyperhomocysteinemia in patients on chronic hemodialysis--a pilot study.
Pöge U; Look M; Gerhardt T; Klehr HU; Sauerbruch T; Woitas RP
Ren Fail; 2004 Nov; 26(6):703-8. PubMed ID: 15600263
[TBL] [Abstract][Full Text] [Related]
2. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
3. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
6. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
[TBL] [Abstract][Full Text] [Related]
8. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
9. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
Elian KM; Hoffer LJ
Metabolism; 2002 Jul; 51(7):881-6. PubMed ID: 12077735
[TBL] [Abstract][Full Text] [Related]
10. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
11. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy.
Touam M; Zingraff J; Jungers P; Chadefaux-Vekemans B; Drüeke T; Massy ZA
Kidney Int; 1999 Dec; 56(6):2292-6. PubMed ID: 10594808
[TBL] [Abstract][Full Text] [Related]
12. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
16. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
Kaplan LN; Mamer OA; Hoffer LJ
Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
19. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
20. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
Bostom AG; Shemin D; Bagley P; Massy ZA; Zanabli A; Christopher K; Spiegel P; Jacques PF; Dworkin L; Selhub J
Circulation; 2000 Jun; 101(24):2829-32. PubMed ID: 10859289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]